Skip to content

Study on Quality Traceability of Biological Products of Cordyceps Zhaqu and Treatment Effect of Insomnia

Study on Quality Traceability of Biological Products of Zhaqu Cordyceps and Treatment Effect of Insomnia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051187
Enrollment
Unknown
Registered
2021-09-15
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

experimental group:oral Zhaqu subentity drink ( Cordyceps subentity body liquid)
control group:placebo

Sponsors

School of Medical Information Engineering, Chengdu University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. People between the ages of 20 and 75, male or female; 2. Those who meet the above-mentioned diagnostic criteria of Chinese and Western medicine for insomnia; 3. Not using sedative drugs recently; 4. Pittsburgh Sleep Quality Index (PSQI) score > 7 points, but anxiety self-rating scale < 50 points; 5. Voluntarily participate in this trial and study, and sign the informed consent form, and do not withdraw easily.

Exclusion criteria

Exclusion criteria: 1. Those who are dependent on sedative and hypnotic drugs; 2. Insomnia caused by abdominal pain, cancer pain, hiccups and other physical diseases or organic brain lesions; 3. Severe heart, liver, renal insufficiency or other serious diseases of the system; 4. Women who are pregnant or breastfeeding; 5. Subjects with mental and neurological diseases who cannot express normally.

Design outcomes

Primary

MeasureTime frame
PSQI scale score;

Countries

China

Contacts

Public ContactZhao Shuting

Chengdu University of Traditional Chinese Medicine

972761035@qq.com+86 15308234379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026